Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.

Surendra Shenoy,Michael Allon,Gerald Beathard,Deborah Brouwer-Maier,Laura M Dember,Mark Glickman,Celeste Lee,Terry Litchfield,Charmaine Lok,Thomas Huber,Prabir Roy-Chaudhury,Jack Work,Melissa West,Haimanot Wasse

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY（2018）

引用 44|浏览29

暂无评分

摘要

Hemodialysis vascular access is the “lifeline” for patients on hemodialysis. Unfortunately, because of its poor patency and significant complication rate, it is also the “Achilles heel” of hemodialysis. For example, the current unassisted arteriovenous fistula (AVF) maturation rate is only

查看译文

关键词

Biological Products,Consensus,Humans,Polytetrafluoroethylene,arteriovenous fistula,clinical trial,renal dialysis,vascular

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要